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Background
Blockade of the sphenopalatine ganglion with Onabotuli-
numtoxinA injections (SphenoBlock) represents a novel
approach for treating intractable chronic cluster headache
(iCCH).
Aim
The aim of this pilot study was to explore the safety
aspects and therapeutic potential of SphenoBlock.
Method
After signing written confirmed consent ten patients
with iCCH were injected with 25 U (n=5) or 50 U
(n=5) onabotulinumtoxinA towards the sphenopalatine
ganglion in an observational study, approved by the
Institutional Review Board, with 6 months follow-up.
The procedure was performed with a novel image-
guided technique. The primary endpoint was to evalu-
ate safety of the procedure, but change in attack
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frequency from baseline to week 4, 12 and 24 was also
registered.
Results
Data for the first 5 patients are presented. One patient
experienced intermittent ipsilateral visual deficits lasting 4
weeks. Patient number 5 was a failed injection. Four
patients were defined as frequency responders (>50%
reduction from baseline) in week 4, 3 patients responded
in week 12, and 2 patients in week 24 (Figure 1). Complete
study data will be presented at the meeting.
Conclusion
SphenoBlock in iCCH shows promising preliminary
results and give reasons for cautious optimism for further
studies on this low-cost alternative treatment of iCCH.
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